Are biosimilars the next tool to guarantee cost-containment for pharmaceutical expenditures?
Biological medicines contain a biological substance that is produced by or derived from a living organism. The active substances of biologicals are usually larger and more complex than those of chemically derived medicines (non-biological medicine). Biologicals are used for the treatment of chronic...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Revisão |
| Jazyk: | angličtina |
| Vydáno: |
2013
|
| On-line přístup: | https://doi.org/10.1007/s10198-013-0538-4 https://link.springer.com/content/pdf/10.1007/s10198-013-0538-4.pdf |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|